Page 79 - 2023 Taiwan Food and Drug Administration Annual Report
P. 79
5Improving Management of Medical
Devices and Cosmetics
Figure 5-1 2022 TFDA Regulatory Science Center of Excellence Workshop
online courses, which facilitated the sharing of group discussion meetings regularly.
principles for evaluating medical device safety
and effectiveness with international standards III. Promotion of third-
and related experiences. TFDA also conducted generation Technical
activities such as keynote speeches, group Cooperation Programme
discussions, case studies, and relevant courses (TCP III)
and activities.
The TCP started in 2004 and entered the
II. Proactive participation in second generation in 2013. In 2019, due to
GHWP in vitro diagnostic regulatory changes concerning the management
medical device related of medical devices in both Taiwan and Europe,
events TFDA continued to plan and announce the third-
generation TCP (TCP III) which will come
As the chair of the In Vitro Diagnostic into effect on January 1, 2022; thus effectively
Medical Device Working Group (WG2- improving the quality of medical devices and
Premarket: IVDD) of the GHWP Technical help domestic medical device manufacturers
Committee (TC), Taiwan has attended strengthen their international competitiveness.
important GHWP meetings and held working
77
